#None #Securities Class Action #Hagens Berman #Ardent Health

Investors Concerned Over Alleged Revenue Deception by Ardent Health

In recent developments, the national law firm Hagens Berman is intensifying its scrutiny of Ardent Health, Inc. (NYSE: ARDT) due to potential misleading practices concerning the company's revenue cycle. This investigation arises in light of a significant securities class action with a crucial lead plaintiff deadline approaching on March 9, 2026. Investors are urged to examine their losses related to ARDT shares within the specified period, from July 18, 2024, to November 12, 2025.

Overview of Allegations

The allegations center around claims that Ardent Health misrepresented the integrity of its revenue recognition systems. Despite providing investors with assurances that thorough reviews of historical collections were utilized to assess receivables, the company admitted late last year to employing what it termed a '180-day cliff' for reserve evaluations. This critical disclosure took investors by surprise, leading to drastic consequences for the company's stock valuations.

The 180-Day Cliff Explanation

According to the lawsuit, the so-called '180-day cliff' strategy implies that accounts only received comprehensive reserve evaluations once they reached six months of age. Critics argue this practice allowed Ardent to inflate its reported receivables during heightened stock valuation periods, misleading investors about the true collectability of their assets.

Professional Liability Reserve Concerns

The circumstances deepened as the lawsuit suggests Ardent did not maintain adequate professional malpractice liability insurance, further undermining its financial credibility. This concern intensified following the revelation of a $54 million surge in professional liability reserves tied to legal settlements and ongoing litigations for claims documented from 2019 to 2022.

Financial Fallout

The compounding issues led to a staggering $42.6 million slash in revenue on November 12, 2025, effectively enhancing the company's recognition of financial discrepancies witnessed over the previous quarters. Following the announcement of these significant adjustments, Ardent Health's stock witnessed a catastrophic plunge, dropping nearly 34% and igniting investor alarm.

Next Steps for Investors

Hagens Berman's partner, Reed Kathrein, is spearheading the investigation. Investors recognizing potential losses or having additional information are encouraged to reach out in haste, as the impending deadline could dictate the course of the lawsuit. Notably, whistleblowers with non-public information are also encouraged to consider their options under the new SEC Whistleblower program, which may offer substantial financial incentives for original information.

As a leading firm in securities class actions with a robust track record, Hagens Berman aims to hold companies accountable for corporate negligence and protect shareholder rights.

If you believe you hold a stake in this incident or have further queries related to the evolving case against Ardent Health, do not hesitate to reach out to Hagens Berman for insights and support. Their formidable history reveals a commitment to addressing corporate accountability and safeguarding investor interests in complex litigation scenarios.

For additional information regarding tales of corporate missteps or advice on managing associated risks, consider following Hagens Berman for ongoing updates. This alert is just the beginning of a potentially extensive investigation highlighting the importance of transparency and accountability in corporate governance.